Today in 2026, the number of new achievements cropping up each year is nothing short of astonishing. Modern medicine’s ability to heal previously unhealable parts of the body – from brains to hearts to compound fractures and nerve disorders – continues to amaze. Now, stem cell treatments are the newest addition to the healing repertoire. [Read more…]
Top Benefits of Stem Cell Research: Pros and Cons
Stem cells are in a position to revolutionize the way doctors treat disease. Among emerging medical technologies, stem cells are the most exciting because of their enormous potential.
In some cases, stem cell research has discovered medical treatments that were thought unimaginable a decade earlier.
There is a lot of public discourse on the ethics of stem cell therapy and certain legal restrictions that limit research, but what scientists are discovering in spite of these hurdles is truly amazing. [Read more…]
BBG Advanced Therapies collects first cell donation on one-of-a-kind bus
New vehicle to help enable lifesaving new advanced therapies
The world’s only mobile leukapheresis center recorded its first donation on Monday, Oct. 20, marking the beginning of a new era for global healthcare.
The BBG Advanced Therapies mobile leukapheresis center, the first of its kind in the world, can help improve access to lifesaving treatments across an area of almost 70,000 square miles currently underserved by next-generation advanced therapies. [Read more…]
The Emerging Role of Exosome Therapeutics in 2026
Exosomes are extracellular vesicles (EVs) of endosomal origin that range in size between 30 and 150 nanometers. Exosomes are secreted by a wide range of cells, since virtually all living cells utilize exosome-mediated communication. Exosomes carry cell-specific cargos of proteins, lipids, and nucleic acids that are selectively taken up by recipient cells. [Read more…]
The Future of Allogeneic Cell Therapy is Off-the-Shelf and iPSC-Based – An Interview with Cellistic’s Founder and CTO, Stefan Braam, PhD
In the rapidly evolving field of cell therapy, scalability and accessibility remain two of the biggest challenges for widespread patient impact. Cellistic, a leading company that is pioneering allogeneic cell therapy solutions, is tackling these obstacles head-on with its novel induced pluripotent stem cell (iPSC) technologies. In this interview, Stefan Braam, PhD, Founder & Chief Technical Officer of Cellistic, shares insights into the company’s journey, its innovative platforms—including Pulse™, Echo™, and the newly introduced Allo Chassis™—and how these advancements are poised to redefine cell therapy development as we known it.
With a clear focus on efficiency, cost reduction, and clinical translation, Cellistic is at the forefront of making off-the-shelf, immune-cloaked cell therapies a reality. Enjoy! [Read more…]
- « Previous Page
- 1
- …
- 31
- 32
- 33
- 34
- 35
- …
- 334
- Next Page »